Keefe_2015_Neuropsychopharmacology_40_3053

Reference

Title : Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an alpha7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia - Keefe_2015_Neuropsychopharmacology_40_3053
Author(s) : Keefe RS , Meltzer HA , Dgetluck N , Gawryl M , Koenig G , Moebius HJ , Lombardo I , Hilt DC
Ref : Neuropsychopharmacology , 40 :3053 , 2015
Abstract : Keefe_2015_Neuropsychopharmacology_40_3053
ESTHER : Keefe_2015_Neuropsychopharmacology_40_3053
PubMedSearch : Keefe_2015_Neuropsychopharmacology_40_3053
PubMedID: 26089183

Related information

Citations formats

Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, Lombardo I, Hilt DC (2015)
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an alpha7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Neuropsychopharmacology 40 :3053

Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, Lombardo I, Hilt DC (2015)
Neuropsychopharmacology 40 :3053